Get started
Author

Jennifer Ensminger

Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor Board
2017 · W. Brian Dalton, Patrick M. Forde, et al. · JCO Precision Oncology · 94
A Pilot Randomized Sham-Controlled Trial of MC5-A Scrambler Therapy in the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy (CIPN)
2019 · Thomas J. Smith, A. Rab Razzak, et al. · Journal of Palliative Care · 50
A pilot randomized sham-controlled trial of MC5-A scrambler therapy in the treatment of chronic chemotherapy-induced peripheral neuropathy (CIPN).
2018 · Thomas J. Smith, A. Rab Razzak, et al. · Journal of Clinical Oncology · 3
Abstract P6-10-07: Activating HER2 missense mutations in HER2-negative metastatic breast cancer
2020 · Mirat Shah, Jennifer Ensminger, et al. · Cancer Research
Abstract PD10-07: Patient reported outcomes and early discontinuation of adjuvant endocrine therapy according to neighborhood poverty rate
2020 · Ramy Sedhom, Amanda Blackford, et al. · Cancer Research
Abstract P4-01-16: Detection of plasma tumor DNA (ptDNA) in patients with hormone receptor-positive HER2-negative (HR+HER2-) early breast cancer (EBC) in clinical remission
2019 · M Shah, N Hunter, et al. · Cancer Research
Patient-reported outcomes and factors associated with early discontinuation of adjuvant endocrine therapy in premenopausal women with breast cancer
2018 · Karen Smith, Amanda Blackford, et al. · The Breast
Addressing the risk of infertility in young women with breast cancer (BC): A quality improvement (QI) intervention.
2017 · Karen L. Smith, Enoch Cheung, et al. · Journal of Clinical Oncology
Works count: 8
Citation count: 147
H-index: 3
I10-index: 2
Year
Topic
Type